Green Light for the Reopening? And the Retail Name One Trader Is Adding to Their Cart
CNBC's "Fast Money"
00:00
Merk's New Pill
Merk's new pill is a "narrative change," says Jeff Meechams, senior farmer analyst at bava securities. But does it take the fear of getting 'dealta' off the table? No, i don't know if it takes it off the table., he says. He reiterates his hold writing on the stock with an 80 dollar price target.
Play episode from 08:08
Transcript
